Results 151 to 160 of about 11,187 (212)

Clinical Features of Human Parvovirus B19-Associated Encephalitis Identified in the Dakar Region, Senegal, and Viral Genome Characterization. [PDF]

Viruses
Seye AO, Top FK, Mbanne M, Diagne MM, Faye O, Sall AA, Dia N, Heraud JM, Faye M.   +8 more
europepmc   +1 more source

Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools - United States, 2024. [PDF]

MMWR Morb Mortal Wkly Rep
Alfego D, Hernandez-Romieu AC, Briggs-Hagen M, Dietz S, Gillim L, Dale SE, Grover A, Albrecht J, Sesok-Pizzini D, Eisenberg M, Gregory CO, Poirier B.   +11 more
europepmc   +1 more source

Notes from the Field: Increase in Diagnoses of Human Parvovirus B19-Associated Aplastic Crises in Children and Adolescents with Sickle Cell Disease - Atlanta, Georgia, December 14, 2023-September 30, 2024. [PDF]

MMWR Morb Mortal Wkly Rep
Yee MEM, Kalmus GG, Patel AP, Payne JN, Tang A, Gee BE.   +5 more
europepmc   +1 more source

[Seroprevalence and infection by human parvovirus B19 in pregnant women from Córdoba, Argentina, 2021-2022] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Dicuatro N, Colazo Salbetti MB, Boggio GA, Ortiz E, Pedranti M, Olivera NL, Lucchini H, González A, Resino C, Moreno L, Adamo M.   +10 more
europepmc   +1 more source

Seroepidemiology of Human Parvovirus B19 Infection among the Population of Vojvodina, Serbia, over a 16-Year Period (2008-2023). [PDF]

Viruses
Vuković V, Patić A, Ristić M, Kovačević G, Hrnjaković Cvjetković I, Petrović V.   +5 more
europepmc   +1 more source

[Clinical characteristics of human parvovirus B19 infection after allogeneic stem cell transplantation]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhang J, Ma R, Luo XY, Zhang XH, Xu LP, Wang Y, Mo XD, Lyu M, Liu KY, Huang XJ, Sun YQ.   +10 more
europepmc   +1 more source

PARVOVIRUS B19 IN HUMAN DISEASE

Annual Review of Medicine, 1997
▪ Abstract  Parvovirus B19, the only known human pathogenic parvovirus, is associated with a wide range of disease manifestations. In healthy individuals, the major presentation of B19 infection is erythema infectiosum. In patients with underlying hemolytic disorders, infection is the primary cause of transient aplastic crisis.
Kevin E Brown, Neal S Young
exaly   +4 more sources

Human parvovirus B19 infection and autoimmunity

Autoimmunity Reviews, 2008
Human parvovirus B19 infection is responsible for a wide range of human diseases ranging from mild erythema infectiosum in immunocompetent children to fetal loss in primary infected pregnant women and aplastic anemia or lethal cytopenias in adult immunocompromised patients.
Claudio Lunardi, Elisa Tinazzi, Caterina Bason   +2 more
exaly   +5 more sources

Primary Infection by Human Parvovirus B19

Dermatology, 2009
We describe a case of primary infection by human parvovirus B19 in a 20-year-old woman; it manifested as erythemato-maculo-papular lesions, pharyngotonsillitis, lymphadenopathy, fever, arthralgia and myalgia, asthenia and anorexia. Laboratory tests revealed anaemia, leucopenia, thrombocytopaenia and a rise in some inflammatory indices.
S. Veraldi, G. Rizzitelli, G. Lunghi, R. Cardone   +3 more
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Human Parvovirus B19 in Rheumatoid Arthritis

International Reviews of Immunology, 1998
Viral arthritis occurs transiently in most cases, because the infection is self limiting. The arthropathy associated with human parvovirus B19, however, often lasts for more than 2 years and their clinical symptoms may resemble with those of rheumatoid arthritis.
Tomonori Ishii, Kazuo Sugamura
exaly   +3 more sources